Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001415889-24-003999

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cooper Simon Peter CHIEF MEDICAL OFFICER 2024-02-13 Grant or award · Employee Stock Option (right to buy) +40,000 40,000 D
Loading xslF345X05/form4-02162024_010205.xml…